The selective inhibitors of NOS, COX, or the both may provide a new approach for the treatment of hematologicalmalignancies.
针对NOS、COX或两者的选择性抑制剂为血液系统恶性肿瘤的治疗提供了新的线索。
2
Objective Expoloring the detection of minimal residual malignant cells in bone marrow from children with hematologicalmalignancies to predict the prognosis.
目的探讨以恶性血液肿瘤患儿骨髓微量残留病检测预测预后的可能性。
3
Conclusion Phenylbutyrate combined with other differentiation agents may be an effective differentiation therapy in a proportion of hematologicalmalignancies.